Pharmacological targeting of endoplasmic reticulum stress in disease

SJ Marciniak, JE Chambers, D Ron - Nature reviews Drug discovery, 2022 - nature.com
The accumulation of misfolded proteins in the endoplasmic reticulum (ER) leads to ER
stress, resulting in activation of the unfolded protein response (UPR) that aims to restore …

[HTML][HTML] The emerging role of XBP1 in cancer

S Chen, J Chen, X Hua, Y Sun, R Cui, J Sha… - Biomedicine & …, 2020 - Elsevier
X-box binding protein 1 (XBP1) is a unique basic-region leucine zipper (bZIP) transcription
factor whose dynamic form is controlled by an alternative splicing response upon …

[HTML][HTML] Valosin-containing protein (VCP)/p97: a prognostic biomarker and therapeutic target in cancer

S Costantini, F Capone, A Polo, P Bagnara… - International journal of …, 2021 - mdpi.com
Valosin-containing protein (VCP)/p97, a member of the AAA+ ATPase family, is a molecular
chaperone recruited to the endoplasmic reticulum (ER) membrane by binding to membrane …

Pharmacological effectors of GRP78 chaperone in cancers

C Bailly, MJ Waring - Biochemical Pharmacology, 2019 - Elsevier
The protein chaperone GRP78 is a master regulator of endoplasmic reticulum (ER) functions
and is frequently over-expressed at the surface of cancer cells where it contributes to chemo …

Structural basis of p97 inhibition by the site-selective anticancer compound CB-5083

WK Tang, T Odzorig, W **, D **a - Molecular pharmacology, 2019 - Elsevier
Inhibition of p97, a key player in the ubiquitin-proteasome degradation pathway, has been
proposed as a treatment of cancer. This concept was nearly realized recently when a potent …

ER stress and unfolded protein response in leukemia: friend, foe, or both?

K Féral, M Jaud, C Philippe, D Di Bella, S Pyronnet… - Biomolecules, 2021 - mdpi.com
The unfolded protein response (UPR) is an evolutionarily conserved adaptive signaling
pathway triggered by a stress of the endoplasmic reticulum (ER) lumen compartment, which …

Profiling and functional analysis of circular RNAs in acute promyelocytic leukemia and their dynamic regulation during all-trans retinoic acid treatment

S Li, Y Ma, Y Tan, X Ma, M Zhao, B Chen… - Cell death & …, 2018 - nature.com
Circular RNAs (circRNAs) are a novel class of powerful regulators in gene expression and
participate in the pathogenesis of many diseases, including cancer. However, little is known …

[HTML][HTML] Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia

D Wang, T Zeng, Z Lin, L Yan, F Wang, L Tang… - Biomedicine & …, 2020 - Elsevier
Background Acute myeloid leukemia (AML) is a common hematopoietic malignancy with
invasive activity. Drug resistance greatly contributes to the poor efficacy of chemotherapy in …

[HTML][HTML] IRE1α inhibitors as a promising therapeutic strategy in blood malignancies

W Wiese, N Siwecka, A Wawrzynkiewicz… - Cancers, 2022 - mdpi.com
Simple Summary Blood malignancies account for 6.9% of all cancer deaths. Inositol-
requiring enzyme 1 alpha (IRE1α), a part of the unfolded protein response (UPR), has been …

VCP/p97/Cdc48, a linking of protein homeostasis and cancer therapy

B Lan, S Chai, P Wang, K Wang - Current molecular medicine, 2017 - ingentaconnect.com
VCP/p97/Cdc48, a member of the ATPases associated with diverse cellular activities (AAA)
family, is necessary for the endoplasmic-reticulum-associated protein degradation (ERAD) …